Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Q: What does CUSIP 30050B101 represent in this 13F holders report?

CUSIP 30050B101 is the security identifier for EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in Q2 2024?

239 institutional investors reported EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 30050B101

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding: 112,318,617
Total 13F shares: 129,502,142
Share change: +4,995,415
Total reported value: $2,475,760,428
Put/Call ratio: 224%
Reported price per share: $19.12
Number of holders: 239
Value change: +$40,167,326
Number of buys: 140
Number of sells: 122

Security key

30050B101

Report period

Q2 2024

Institutions

239

Top holders

EVH full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 Evolent Health, Inc. SEC filings Evolent Health, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 30050B101

Newer quarter: Q3 2024 Previous quarter: Q1 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

VANGUARD GROUP INC

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2024

13F Lead comparable stake: 9.7% Showing 1-6 of 15 holder rows.

Rank 1 holder

VANGUARD GROUP INC

13F

Ownership: 9.7%
Position: $357.91M

13F

Rank 2 holder

FMR LLC

13F

Ownership: 9.4%
Position: $347.32M

13F

Rank 3 holder

WELLINGTON MANAGEMENT GROUP LLP

13F

Ownership: 7.9%
Position: $290.31M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	9.7%	$357,905,145 10,915,070 shares	—	31 Mar 2024
FMR LLC	13F Company 13F	9.4%	$347,319,354 10,592,234 shares	—	31 Mar 2024
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	7.9%	$290,310,560 8,853,631 shares	—	31 Mar 2024
BlackRock Finance, Inc.	13F Company 13F	7.4%	$272,005,576 8,295,382 shares	—	31 Mar 2024
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	5.1%	$188,087,768 5,736,132 shares	—	31 Mar 2024
JPMORGAN CHASE & CO	13F Company 13F	4.2%	$155,657,640 4,747,107 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

239

129,502,142

Rows available

239

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

247

Q2 2024 holders

239

Holder diff

-8

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend